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It is difficult to define continuity of care or study its impact on health outcomes. This study took place in three stages. In stage I we
conducted qualitative research with patients, their close relatives and friends, and their key health professionals from which we
derived a number of self completion statements about experienced continuity that were tested for reliability and internal consistency.
A valid and reliable 18-item measure of experienced continuity was developed in stage II. In stage III we interviewed 199 patients with
cancer up to five times over 12 months to ascertain whether their experiences of continuity were associated with their health needs,
psychological status, quality of life, and satisfaction with care. The qualitative data revealed that experienced continuity involved
receiving consistent time and attention, knowing what to expect in the future, coping between service contacts, managing family
consequences, and believing nothing has been overlooked. Transitions between phases of treatment were not associated with
changes in experienced continuity. However, higher experienced continuity predicted lower needs for care, after adjustment for
other potential explanatory factors (standardised regression coefficients ranging from  0.12 (95% CI  0.20,  0.05) to  0.32 (95%
CI  0.41,  0.23)). Higher experienced continuity may be linked to lower health care needs in the future.
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Since 2000 (Department of Health, 2000) cancer care has been the
subject of UK government targets to reduce waiting times for
diagnosis and treatment (Department of Health, website:www.
performance.doh.gov.uk/cancerwaits), the European Working
Time Directive has changed patterns of working and general
practitioners no longer provide out of hours cover for patients.
These changes impact on continuity of care, which is a key
research priority for the Cancer Reform Strategy (Department of
Health, 2006, 2007). The National Institute for Health and Clinical
Excellence guidance on supportive and palliative care recommends
promotion of continuity of care and taking account of patients’
and carers’ views (NICE guidance on palliative and supportive care
for adults with cancer, 2004).
Conceptualising continuity of care
Continuity of care is not easy to define or measure. It involves
consistent information, cross boundary and team continuity,
flexibility in response to need, care from as few professionals as
possible, and a main contact person (Freeman et al, 2000). More
recently, informational, management, and relational continuity
have been described (Centre for Health Services and Policy
Research, 2006) (Box 1). Haggerty et al (2003) defined inter-
personal continuity in terms of the doctor–patient relationship
but regarded it as difficult to measure and were uncertain that it
improves care. Furthermore, we know little about how patients
experience continuity of care and whether this affects their health
outcomes (Haggerty et al, 2003). Cancer will affect one in three
people at some time in their lives. For most cancers, 5-year
survival has been improving steadily over the last 30 years,
especially breast and bowel cancer (Coleman, 1999). As a result,
cancer is becoming a chronic illness with which patients must both
live and face the threat of recurrence. Cancer treatments are often
intensive and disruptive to patients’ lives. Typical patients
encounter several different layers of care during their illness,
Box 1 Types of continuity
Informational continuity—The use of information on past events and personal
circumstances to make current care appropriate for each individual
Management continuity—A consistent and coherent approach to the
management of a health condition that is responsive to a patient’s changing
needs
Relational continuity—An ongoing therapeutic relationship between a patient
and one or more providers Received 24 August 2007; revised 15 November 2007; accepted 27
November 2007; published online 29 January 2008
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sespecially if treatment continues over a protracted period. Thus
continuity is a crucial issue in this field of medical care
Our main questions were: can continuity of cancer care be
defined from the service user’s perspective and do their percep-
tions of continuity affect their health outcomes? We aimed to (1)
use qualitative research to understand how patients and people
close to them experience continuity of care; (2) apply key concepts
arising from the qualitative data to develop a measure of
continuity; and (3) evaluate if patients’ experiences of continuity
of care determine their health outcomes.
MATERIALS AND METHODS
This mixed methods study took place in three stages. In stage I, we
conducted qualitative research with patients, close persons, and
health professionals. In stage II, these data were used to derive a
standardised measure of experienced continuity. In stage III, we
used this measure in a cohort of patients with cancer to ascertain
whether continuity of care was associated with their health needs,
psychological status, quality of life, and satisfaction with care.
Patients were diagnosed with breast, lung or colorectal cancer.
These tumour sites were chosen as they are commonly occurring
and provided an overall gender balance. Sampling was purposive
and we aimed to recruit equal numbers from each cancer type at
each of five treatment phases (Morse and Fife, 1998; Farell and
Lewis, 2000):
(1) Initial diagnosis defined as within 4 weeks of receipt of
diagnosis and before specific treatment begins
(2) End of first treatment when first treatment is defined as the
treatment plan agreed by the treating clinical team
(3) Remission defined as having been clinically disease-free for a
minimum of 6 months
(4) Relapse defined as first recurrence of cancer of original cell
type leading to re-presentation to secondary services
(5) Referral to specialist palliative care, which may occur at any
time during illness, but usually when symptoms are severe or
the terminal phase is anticipated.
Stage I: qualitative study
We obtained ethical approval from a Local Research Ethics
Committee and the study was conducted over eight months in
2002 and 2003. We recruited participants from five general practices
across north London to reflect as wide a range of socio-
demographic variability as possible. Recruiting from primary care,
we aimed to reach patients who might have been lost to follow-up
in secondary care. Practise staff used electronic records to identify
patients with lung, colorectal, and breast cancers at each treatment
phase and obtained consent to pass their details to the research
team. Patients and close persons were interviewed by AI and HA in
their homes or the general practise according to their wishes. At
first research contact, patients nominated one close person and up
to two key health professionals who might also take part. We
intended to place most emphasis on the views of patients and close
persons but also interviewed key professionals where possible
to understand how these differed (Nazareth et al, in press). We
avoided the term ‘continuity of care’ in interviews, attempting
instead to focus on consistent services and to encourage patients to
reflect on issues that captured the balances needed to ensure that
patients could access diagnosis, treatment, and follow-up while
maintaining a sense of normality and hope for the future.
Interviewers used a set of prompts that were modified in response
to piloting. Health-care professionals were also asked how
continuity of cancer services might be improved. We aimed to
recruit until no new themes emerged from the data or we reached a
maximum of 30 patients.
Analysis of qualitative data
Interviews were read several times independently and coded by
two researchers; there was a mean rate of disagreement in codes of
9.1%, which were settled by consensus. The codes were indexed
and transferred to QSR NVivo v1.2 for framework analysis
(Neuendorf, 2002). Data were discussed repeatedly at research
team meetings and a collective decision was taken to stop
interviewing after 28 patients had been recruited as no new
themes were emerging. The detailed results of this qualitative study
are reported elsewhere (Nazareth et al, in press). Here we report
how the qualitative data were used to construct a number of
statements on experienced continuity of care that were standar-
dised and used in our cohort study.
Stage II: development of the measure of experienced
continuity
MK, LJ, and IN who have research and clinical experience in
cancer and AI and HA who conducted many of the qualitative
interviews discussed each theme in the qualitative data. We
used the Haggerty model (Haggerty et al, 2003) as a theoretical
framework in seeking to establish a set of statements from the
qualitative analysis that related to themes of continuity. We kept
the instrument brief (20 statements) and circulated it to the project
steering committee and clinicians for further modification. On
the advice of user representatives we used a Likert format with
five responses to each statement ranging from ‘strongly agree’
to ‘strongly disagree’. We evaluated test-retest reliability of the
20-item instrument by asking 38 patients with a range of cancers in
different stages in treatment (who were not part of the cohort
described below) to complete it on two occasions 2–3 weeks apart.
Internal consistency of the statements was estimated in the
baseline cohort data.
Stage III: cohort study
We undertook the cohort study in three National Cancer Networks
in London between May 2003 and August 2005. Sampling was
purposive to ensure consistency of recruitment across the three
networks. Staff approached patients with breast, lung, or colorectal
cancer in the five phases of treatment and sought consent to pass
their details to the research team. Recruitment was assisted by
National Cancer Research Network research staff. After giving
consent for participation in the cohort, patients undertook
assessments in their own homes. Each patient provided informa-
tion on their socio-demographic characteristics, type of cancer,
treatment phase, and cancer service network. They then completed
the 20 statements developed on experienced continuity and a
number of other measures:
1. Needs for care: the Supportive Care Needs Survey (Bonevski
et al, 2000; Steginga et al, 2001) measures physical and daily
living, psychological, health system and information, sexuality,
and patient care and support needs for care.
2. Quality of life was measured using the Euroqol (EuroQol
Group, 1990).
3. Psychological status was assessed using the 28-item General
Health Questionnaire (Goldberg and Williams, 1988).
4. Satisfaction: As there was no standardised measure of
satisfaction with cancer services, we developed visual analogue
scales for satisfaction with overall care, continuity of care,
supportive care, information needs, and quality of commu-
nication (scored 0 to 10 towards higher satisfaction). The five
scales were summed to a total score.
All participants completed these measures again at face-to-face
assessments, 3, 6, 9, and 12 months later. The interview was piloted
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swith a number of patients prior to embarking on the continuity
study and modifications made. Research personnel changed
slightly throughout the study and so occasionally patients would
be interviewed by a different researcher at a follow-up point. All
the interviews were carried out by AI, HA, AR, HC, and PA. Ethical
approval was obtained from a Multicentre Ethics Committee.
Statistical analysis of the quantitative research and sample
size
We conducted all analyses using Stata release 9.
Reliability of the continuity statements We estimated test-retest
reliability in our separate reliability study by condensing scores for
each statement (1 for each affirmation of continuity and 0 for other
responses) and calculating the intra-class correlation coefficient.
Internal consistency was estimated in patients in the cohort study
using Cronbach’s alpha.
Analysis of the cohort We explored the heterogeneity of the
cohort data by testing whether patient experiences were equivalent
in each phase of treatment, regardless of the time point, using the
w
2 test for categorical and F test for continuous variables. We
undertook a multilevel model analysis with two levels (time period
nested within patients) and a random intercept. We estimated the
parameters in the multilevel model using the maximum likelihood
method. Cancer networks and centres were included as covariates
in the regression models. Treatment phase, cancer network,
treatment site, follow-up point, and transition from one treatment
phase to another were significantly associated with missing data on
our main outcomes and were adjusted for in our regression
models. Multiple imputation of missing data by chained equation
method was used to derive five imputed data sets (Royston, 2004,
2005a,b; van Buuren et al, 2006). We fitted a multilevel model to
each of the five sets, averaging regression coefficients and using
Rubin’s rule to obtain the correct s.e. (Schafer, 1999). We did not
impute missing demographic data as these could be carried
forward from baseline. We used a time lag predictive model in
which experienced continuity score is related to each outcome
measure one time point later.
Sample size for the cohort study We could not estimate a priori
the size of any association between our measure of experienced
continuity and our main outcomes; thus we aimed to recruit 250
patients, given the funding constraints of the study. We can
however, estimate the statistical soundness of our analysis. Since
several regression models were fitted, the size of the data varied
due to missing values. There were at least 337 observations
available for these analyses. Using rule of thumb of 10 participants
for each variable (Harrell, 2001) and inflating the sample size
required due to the presence of repeated measurements by 1.32,
160 participants are required to estimate up to 12 coefficients in a
model. The inflation factor was estimated using an average cluster
size of approximately two (337 observations/199 participants) and
the largest intra-cluster correlation coefficient was (ICC) estimated
from the data of 0.32 (mean ICC 0.04).
RESULTS
Stage I: participants in the qualitative study
Twelve were women with breast cancer (mean age 58 years), nine
had colorectal cancer (five women, mean age 67 years), and seven
had lung cancer (four women, mean age 71 years). Twenty-four
nominated a close person, of whom 18 agreed to interview; eight
were nominated by patients with breast cancer, five by those with
colorectal cancer, and five by those with lung cancer. Seven were
spouses or partners, five were adult daughters, five were friends,
and one was a colleague. Sixteen patients nominated at least one
key professional; 13 nominated general practitioners, and 10
nominated secondary care professionals, seven of whom were
nurses (see Nazareth et al, in press for further detail).
Themes in the qualitative analysis
Patients talked mostly about consistency of services, whether
service providers had a collective memory about their care, and
how they coped between service contacts. Unlike the professionals
who focused mainly on the structure of services, patients focused
on how well they were known to services and what to expect in the
future. All patients, close persons and professionals emphasised
receiving sufficient time and attention from services and ensuring
nothing had been overlooked. Patients and close persons wanted to
be well informed about treatments and side effects. Managing the
impact of treatments and maintaining a feeling of normality were
crucial. Several patients indicated their need at times for
discontinuity by wanting to forget the illness and achieve a sense
of normality. Family roles affected patients’ and close persons’
attitudes to illness and in turn their sustained engagement with
care. How services responded and what professionals remembered
about them influenced their perceptions of continuity. Patients
were generally accepting of their care, whereas close persons
expressed more concern at perceived delays and lacked confidence
in service providers. General Practitioners found themselves
advising on future treatment decisions and the likely course of
illness, as well as chasing up appointments with secondary care.
Clinical nurse specialists were aware of their key role for patients,
particularly with regard to trust and continuity (Nazareth et al,i n
press).
Stage II: the measure of experienced continuity
We condensed the qualitative themes into a 20-item instrument.
However, two statements were eventually discarded as they could
not apply to all patients (one on home social services and one on
social security benefits). The 18 items remaining (Box 2) had high
internal consistency at baseline in the prospective cohort data
(Cronbach’s alpha 0.87) and no single item removal improved on this.
Box 2 Statements on experienced continuity of care
Item
no. Items
1 I have received enough time and attention from the cancer services
2 I do not see the cancer services often enough
3 I am getting consistent information about my illness from health care
staff
4 I frequently have to chase up cancer services to get things done
5 I have been well informed about what my treatment will involve over
the next few months
6 I am aware of what side-effects to expect from my cancer treatments
7 I have been told what to expect in terms of my overall health over
the next few months
8 I feel out of touch with the cancer services between appointments
9 I feel able to cope with minor complications that may arise
10 I am coping well between my appointments with the cancer services
11 I have difficulty accepting the limitations my health places on my life
12 I feel supported by the people closest to me
13 I feel my friends and relatives are able to help me cope with my illness
14 I am worried about the emotional state of the people closest to me
15 I feel I depend too much on my friends or relatives
16 I have received some misleading information from the cancer services
17 I am content that I have received a full medical examination with
regard to my cancer
18 I am worried that some things may have been overlooked
Continuity of care and health outcomes
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sScores on questions 1, 3, 5–7, 9, 10, 12, 13, and 17 were reversed so
that a high total score indicated high experienced continuity.
Thirty-eight patients entered into the separate test-retest
reliability study of whom 30 (20 women) (79%) completed it a
second time. Of the latter, eight patients had breast cancer, eight
colorectal, four lung and one brain cancer, and nine were receiving
palliative care for a range of cancers. Their mean age was 62.2
years (s.d. 10.6). The intra-class correlation for total continuity
score was 0.82 (95% confidence intervals (CI) 0.70, 0.94) indicating
good reliability.
Total approached for study by services=311
Attrition=6 (0.03%)
Attrition=23 (11.5%)
Attrition=23 (13.0%)
Attrition=17 (11.0%)
Attrition=15 (10.9%)
a This patient did not enter the study at a later point because they subsequently died. Therefore, 199 patients participated in the study at some point.
- Patient died (n=6) 
Interviewed=199 (99.6%)
-In person (n=198)  
-Postal (n=1) 
Missed interview=1 (0.01%)
a
-Patient ill (n=1)
Interviewed=149 (74.5%)
-In person (n=146)
-Postal (n=3) 
Interviewed=119 (67.2%)
-In person (n=119)  
-Postal (n=0)
Interviewed=102 (66.2%)
-In person (n=100)  
-Postal (n=2) 
Consented=206 
(75.5%) 
Refused=67 (24.5%) 
Interviewed=111 (81.0%)
-In person (n=105)  
-Postal (n=6) 
Missed interview=28 (14.0%) 
-Uncontactable (n=6)  -Not willing (n=2) 
-Patient ill (n=14)                  -Too busy (n=5) 
-Undetermined reasons (n=1) 
Missed interview=35 (19.8%) 
-Uncontactable (n=13)  -Not willing (n=1) 
-Patient ill (n=15) -Unreturned  postal  (n=2) 
-Undetermined reasons (n=1)  -Too busy (n=3)
Missed interview=35 (22.7%) 
-Uncontactable (n=17)  -Close person died (n=1) 
-Patient ill (n=10)                  -Too busy (n=4) 
-Undetermined reasons (n=1)  -Unreturned postal (n=2) 
Missed interview=11 (8.0%)
-Uncontactable (n=8)  -Not willing (n=0) 
-Patient ill (n=3) -Close person died (n=0)
-Close person ill (n=0)  -Undetermined reasons (n=0) 
-Too busy (n=0)  -Unreturned postal (n=0) 
-Withdrawn (n=5) 
-Withdrawn (n=6) 
-Withdrawn (n=8) 
-Withdrawn (n=3) 
-Patient died (n=6) 
-Patient died (n=17)
-Patient died (n=8)
-Patient died (n=7)
-Became ineligible (n=1)
-Became ineligible (n=1)
-Became ineligible (n=0)
Total interviews=680 Total missed=110  Total attrition=84
Refused=38 (12.2%)  Referred=273 
(87.8%) 
 -Study  closed  (n=5)
Consent 
Time 1 
Time 2
Time 3
Time 4
Time 5
Totals 
All 
Referrals 
Figure 1 Flow diagram study.
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sStage III: prospective cohort study
Response rates and characteristics of the population at recruit-
ment Two hundred and seventy-three patients (103, 78, and 92 in
each cancer network), allowed their details to be passed to the
research team. When contacted 199 (73%) agreed to participate
and 74 refused. We could not record data on those who refused for
ethical reasons. Participants lost at one follow-up point occasion-
ally returned to the cohort at a subsequent point (Figure 1). As
expected, there was considerable attrition due to death.
Clinical, psychological, and spiritual status at recruitment There
were no socio-demographic differences between patients in the five
treatment phases at baseline (Table 1). Eighty-three per cent of
participants reported that they had a main contact person in the
cancer services. Other principal differences were: (1) lowest needs
for care during remission; (2) lowest quality of life after relapse
and during palliative care; and (3) best psychological status in
remission and worst at relapse (Table 2). Satisfaction with services
was somewhat higher in remission. Mean scores on experienced
continuity did not vary with treatment phase or type of cancer.
This lack of heterogeneity in our main variable confirmed that the
data could be analysed as a whole.
Experienced continuity and health outcomes over 12 months Eighty-
one (41%) people made at least one transition between treatment
phases, mostly between diagnosis, first treatment, and remission.
One person moved back from palliative care into remission and
four moved from first relapse into a further remission. Experi-
enced continuity of care did not change significantly in the whole
cohort over time (per follow-up point, standardised regression
coefficient B  0.01, CI  0.06, 0.03). There was also no significant
association between continuity and a transition from one
treatment phase to another (standardised B  0.25, CI  0.51,
0.01). After adjustment for potential confounding influences, mean
continuity score at one time point was negatively predictive in the
complete case and imputed data sets of all subscales of the
Supportive Care Needs Survey at a forthcoming time point
(Table 3). This means that higher experienced continuity at one
time point predicted lower needs for supportive care at the next.
The result for the association between continuity and satisfaction
was not replicated in the imputed data (Table 3) and therefore
needs to be interpreted with caution.
A complex non-linear relationship was observed between the
health outcomes measured by the Euroqol and General Health
Questionnaire, and the needs identified in the Supportive Care
Needs Survey. This may go some way to explain why continuity of
care was not directly associated with these health outcomes.
DISCUSSION
Main findings
Rather than adopting a top-down theoretical approach to
continuity, we used a bottom-up empirical approach to explore
Table 1 Patients’ characteristics by phase of treatment at recruitment
Treatment phase
All
(N¼199)
Initial
diagnosis
(N¼45)
Completion
first
treatment
(N¼48)
Remission
(N¼46)
Relapse
(N¼27)
Specialist
palliative care
(N¼33)
N Mean s.d. N Mean s.d. N Mean s.d. N Mean s.d. N Mean s.d. N Mean s.d. P-value
Age in years 191 61.2 11.8 45 60.0 11.1 43 60.3 11.1 45 61.2 11.6 25 61.7 13.2 33 63.2 13.4 0.810
N % N % N % N % N % N %
Gender
Male 63 31.7 14 30.4 15 32.6 13 27.7 11 42.3 10 29.4 0.765
Female 136 68.3 32 69.6 31 67.4 34 72.3 15 57.7 24 70.6
Marital status
Single 35 17.6 11 23.9 7 15.2 8 17.0 6 23.1 3 8.8
Married/cohabiting 121 60.8 27 58.7 30 65.2 24 51.1 17 65.4 23 67.7 0.190
Formerly married
a 41 20.6 8 17.4 7 15.2 15 31.9 3 11.5 8 23.5
Household (lives with)
Alone 56 28.1 15 32.6 11 23.9 18 38.3 5 19.2 7 20.6
Spouse/partner only 77 38.7 15 32.6 15 32.6 16 34.0 13 50.0 18 52.9 0.520
Anyone else 62 31.2 15 32.6 19 41.3 12 25.5 7 26.9 9 26.5
Socio-economic class
Group A
b 111 55.8 18 39.1 29 63.0 27 57.5 15 57.7 22 64.7 0.137
Group B
c 74 37.2 22 47.8 16 34.8 18 38.3 10 38.5 8 23.5
Ethnicity
White British 150 75.4 33 71.7 36 78.3 36 76.6 19 73.1 26 76.5
Any other White
background
18 9.1 4 8.7 3 6.5 6 12.8 2 7.7 3 8.8
Black/Black mixed
background
15 7.5 5 10.9 2 4.4 2 4.3 3 11.5 3 8.8 0.497
Asian/Asian mixed
background
6 3.0 1 2.2 0 0.0 3 6.4 2 7.7 0 0.0
Any other background 8 4.0 3 6.6 4 8.7 0 0.0 0 0.0 1 2.9
aFormerly married¼separated, divorced or widowed.
bGroup A¼Socio-economic classes I, II and III non-manual.
cGroup B¼Socio-economic classes III manual, IV, V and
housewife/househusband.
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show continuity is experienced by patients. Experienced continuity
is a concept involving consistent time and attention, knowing what
to expect in the future, coping between service contacts, managing
family consequences and believing nothing in treatment has been
overlooked. Our measure of experienced continuity had validity
based on patients’, close persons’ and health professionals’ grass-
roots opinions, and the total score has acceptable test-retest
reliability. Eleven statements concern some of the issues that
professionals face in delivering continuity of care (statements 1–8
and 16–18). Transitions between phases of treatment have no
impact on continuity but high experienced continuity of care is
predictive of fewer future needs for supportive care.
Strengths and limitations of the study
Some conceptual overlap between continuity and quality of care is
possible as services that offer good continuity are often of higher
quality. Although there are similarities in content between some
items in our measure of experienced continuity and those in the
Supportive Health Needs Survey’s subscale health system and
information needs, this is not the case for the other subscales.
Residual confounding in our time-lag analysis is possible and,
given the repeated measures of our analysis, it is likely that we are
overfitting the estimates of the association between experienced
continuity and health outcomes. Nevertheless, our multilevel
approach helped to reduce this latter possibility. Our cohort
recruitment fell short of 250, mainly because people who indicated
they would participate subsequently changed their minds. Attri-
tion due to death or incapacitating illness was the main limitation
of the study. Imputation methods are currently limited within
multilevel, repeated measures analyses because they assume
independence of the observations. Thus we regard our imputed
data as a sensitivity analysis to be as cautious as possible. Although
there was some consistency in the research staff conducting
interviews, during the course of the three stages of the work, all
research assistant personnel changed. We cannot therefore
comment on the possible effects on experienced continuity of
the conduct of the research itself. Finally, although covering areas
with varying socio-economic conditions and services, it may not
be possible to generalise our findings beyond London.
Experienced continuity
Experienced continuity of care will not simply mirror continuity as
delivered by health professionals. It is a measure of the outcome
rather than the delivery of care. In our study, patients experienced
consistent care in terms of sufficient knowledge about the cancer
and its prognosis, a perception of ready access to services,
confidence that they can manage when not in touch with services
and assurance that their families can cope. Coping between
appointments may mean patients can visualise in their mind’s eye
a stable and consistent service. Good family relationships with few
secrets may mean that communication with professionals is
facilitated. Patients in our qualitative study seldom mentioned
communication between services or a key person to contact.
However, patients and close persons are often not aware of
Table 2 Scores on experienced continuity and health and service outcomes stratified by phase of cancer treatment at recruitment
Treatment phase
All
(N¼199)
Phase 1 diagnosis
(N¼46)
Phase 2
completion first
treatment
(N¼46)
Phase 3 In remission
(N¼47)
Phase 4 On relapse
(N¼26)
Phase 5 Specialist
palliative care
(N¼34)
N Mean s.d. N Mean s.d. N Mean s.d. N Mean s.d. N Mean s.d. N Mean s.d. P-value
Continuity of care
Total score on 18 statements
(range: 0–72)
181 51.8 9.9 45 52.1 9.3 41 50.8 12.9 41 52.1 7.9 24 53.2 6.1 30 51.0 11.4 0.879
Satisfaction
Satisfaction (range: 0–50) 191 41.7 8.8 42 41.5 8.8 46 39.3 9.9 46 44.0 6.3 26 43.6 6.8 31 40.8 10.8 0.086
SCNS
SCNS Physical and daily living
needs (range 0–100)
194 11.7 4.7 44 12.0 4.4 45 11.6 4.4 46 9.4 4.1 27 12.7 5.2 33 13.4 4.6 0.001
SCNS Psychological needs
(range 0–100)
186 21.4 8.8 44 21.3 9.5 44 22.8 7.9 45 18.6 7.9 25 25.0 10.7 28 20.6 7.2 0.037
SCNS Patient care+support
needs (range 0–100)
193 11.6 3.7 44 12.8 4.3 46 12.2 4.2 47 9.9 2.7 26 11.7 3.3 30 11.6 2.9 0.003
SCNS Health system
+information needs
(range 0–100)
184 21.8 6.9 42 23.8 8.2 46 24.5 8.4 47 19.1 4.9 25 21.9 3.7 24 19.5 4.6 o0.001
SCNS Sexuality needs (range
0–100)
193 4.3 2.4 44 4.7 2.3 45 4.0 2.0 47 4.3 3.1 25 4.3 3.1 32 4.2 2.2 0.727
Euroqol
Euroqol ED5D
(range:  0.59–1.00)
196 0.67 0.5 46 0.73 0.23 46 0.73 0.23 47 0.78 0.13 26 0.64 0.28 31 0.36 1.1 0.001
Euroqol thermometer (range
0–100)
190 66.6 18.9 43 64.3 20.7 45 69.5 16.4 45 74.8 15.8 26 60.8 20.3 31 58.7 18.1 0.001
GHQ
GHQ Total (range 0–28) 173 6.3 0.4 43 7.2 0.8 39 6.9 0.9 43 4.1 0.8 20 8.5 1.5 28 5.7 0.9 0.01
GHQ caseness
a
Non case 92 (53.2%) 16 (37.2%) 22 (56.4%) 31 (72.1%) 9 (45.0%) 14 (50%) 0.022
Case 81 (46.8) 27 (62.8%) 17 (43.6%) 12 (27.9%) 11 (55.0%) 14 (50%)
aCaseness defined at a threshold of 5/6.
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scommunication between services and may take a key professional
for granted. As the patients in the cohort confirmed, key contact
professionals are already a fundamental part of London’s cancer
services.
Providing continuity
Rather than something professionals offer, continuity is an
interaction between the care setting, the professionals’ management
of it, and patients’ beliefs about and attitudes to those close to them.
For example, if patients have difficulty talking about cancer to their
close friends and family and do not involve them in their treatments,
continuity of care may be placed in jeopardy. How patients cope
between appointments is linked to the concept of self-management
and how to engage patients in their healthcare (Coulter, 2006).
Does experienced continuity matter?
Most evidence on the impact of continuity concerns the delivery of
single interventions such as the availability of a consistent
professional. Considering other diseases using this concept of
delivered continuity, there is evidence for (Parchman et al, 2002)
and against (Gulliford et al, 2006) a relationship with better
glycaemic control (Parchman et al, 2002) in diabetes care.
Enhanced continuity may also improve outcomes in obstetric
care, albeit at the risk of unnecessary interventions (Hodnett,
2000), while a consistent clinician and site for treatment are
associated with higher rates of uptake of screening for cervical
cancer (O’Malley et al, 1997). Continuous primary care provision
also leads to earlier detection of cancer (Reid and Rozier, 2006).
Our study in cancer is the first to suggest that the degree to which
patients experience continuity may reduce their needs for care.
This is particularly the case for health information needs (Table 3),
which, given the content of our continuity instrument, is under-
standable. Continuity was not linearly associated with later quality
of life or psychological status. Although it is possible for the
quality of experienced continuity to have an impact on future
health status, our observation of the complex relationship between
health needs and health outcomes, and the likely role of other
factors such as disease progression, indicate that this relationship
is complex and requires further research.
Transitions in treatment
It is reassuring that transitions between phases of treatment were
not associated with changes in experienced continuity. Although
clinical experience suggests that transitions, such as cessation of
active treatment and referral to specialist palliative care, might
cause a sense of abandonment, we found no such impact on
experienced continuity. It is unlikely that our measure of
experienced continuity lacked sensitivity to such change, given
its demonstrated links with perceived needs for care over time.
Conclusions
Our findings suggest that patients’ experience of continuity is an
outcome of service delivery that can be facilitated rather than
provided. We need to avoid narrow, service-based concepts of
continuity if we are to understand its impact on health outcomes.
Higher experienced continuity may be associated with lower health
care needs in the future. Our findings require confirmation as well as
reflection on how we might ensure that patients’ experiences of
continuity are as positive as possible. We have already begun the first
phase of research into the development, piloting, and testing in a
feasibility randomised controlled trial of an intervention to enhance
continuity of care in cancer. The intervention focuses on enabling
patients to change and improve their experiences of continuity. Such
work also requires application in other areas of chronic care.
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